THE STANDARDIZATION OF HYDROCHLORIC ACID WITH POTASSIUM IODATE AS COMPARED WITH BORAX AND SODIUM CARBONATE AS STANDARD SUBSTANCES | Journal of the American Chemical Society
![Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022 | MMWR Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7140e3_MonitoringMPX_IMAGE_30Sep2022_1200x675_1.jpg?_=70590)
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022 | MMWR
Food Additives, Safety of Adipic Acid as Compared with Citric and Tartaric Acid | Journal of Agricultural and Food Chemistry
![Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain - CHEST Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain - CHEST](https://journal.chestnet.org/cms/asset/42eca783-1056-4387-8f8b-d6cda52808b0/fx1.jpg)
Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain - CHEST
![Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy](https://www.cell.com/cms/attachment/e0a44b6b-e0ee-45f2-a185-5259b0bfed2b/gr1_lrg.jpg)
Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy: Molecular Therapy
Partial Time Regressions as Compared with Individual Trends Author(s): Ragnar Frisch and Frederick V. Waugh Reviewed work(s): So
![Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis | Cirugía Española (English Edition) Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis | Cirugía Española (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//21735077/0000009900000006/v1_202106130552/S2173507721001538/v1_202106130552/en/main.assets/fx1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNevDmstseIgSbQDOqjN6Vz8N9LRUxrCnN2LxWRaNB5HFb3xN/IZ+8FET+7w9hpXAHSFWjNeuEcqXYADRf2xCqjZpZrBfZUk4AZbxmw3Y20gZV6ZNObWWDXMIhVoDom7vSoO+mQVv4r/vMPh30JPtZDzBoT3HuCxX51/3xKEyYuHlGohxfS8y1M8re2/0bRbJS3RebjLdLVD09Aw//+gFk/n0Ao0beNlDwINktN6wj1PI/idTgGDZJuOmK3DW2hBhOw=)
Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis | Cirugía Española (English Edition)
![First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial - The Lancet First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/261e1c1e-db00-4ff4-94e2-1711d550aaea/gr1.gif)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial - The Lancet
![Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 | MMWR Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7149a5_mpoxIncidenceJYNNEOSVaccine_IMAGE_09Dec2022_1200x675.jpg?_=23516)
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 | MMWR
![The U.S. criminal justice system disproportionately hurts Native people: the data, visualized | Prison Policy Initiative The U.S. criminal justice system disproportionately hurts Native people: the data, visualized | Prison Policy Initiative](https://static.prisonpolicy.org/images/incarceration_byrace_2019.png)